Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-09-27 | 2017-12-14 | 23641 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-09-27 | 2017-11-09 | 23644 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2017-11-28 | 2018-03-08 | 30957 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-11-28 | 2018-02-21 | 31028 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-08-26 | 2020-11-09 | 122997 |
APO-RAMIPRIL | 15MG | CAPSULE | Resolved | 2020-09-22 | 2020-12-21 | 124798 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-10-14 | 2020-11-09 | 126306 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-10-28 | 2020-12-21 | 127370 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2020-11-04 | 2020-12-29 | 127754 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-11-04 | 2020-12-21 | 127759 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-11-19 | 2020-12-21 | 128621 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2020-12-28 | 2021-01-26 | 130719 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2020-12-28 | 2021-02-11 | 130722 |
APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2021-01-08 | 2021-02-09 | 131166 |
APO-RAMIPRIL | 5MG | CAPSULE | Resolved | 2021-01-08 | 2021-01-20 | 131176 |
APO-RAMIPRIL | 15MG | CAPSULE | Resolved | 2021-01-29 | 2021-03-24 | 132747 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2021-02-05 | 2021-02-09 | 133388 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-02-12 | 2021-03-09 | 133997 |
APO-RAMIPRIL | 15MG | CAPSULE | Resolved | 2021-02-12 | 2021-03-24 | 134000 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2021-04-09 | 2021-05-03 | 137272 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
APO-HYDROMORPHONE CR | 6MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110959 |
APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |